Corbus Pharmaceuticals Holdings (CRBP) Profit After Tax Growth (5y) (2018 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Profit After Tax Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 112.73 Mn | 84.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.73% |
| Jun 30, 2025 | 14.25% |
| Mar 31, 2025 | 10.56% |
| Dec 31, 2024 | 18.55% |
| Sep 30, 2024 | 7.89% |
| Jun 30, 2024 | -46.04% |
| Mar 31, 2024 | 23.44% |
| Dec 31, 2023 | 14.25% |
| Sep 30, 2023 | 7.19% |
| Jun 30, 2023 | 6.16% |
| Mar 31, 2023 | -8.70% |
| Dec 31, 2022 | -0.34% |
| Sep 30, 2022 | -4.95% |
| Jun 30, 2022 | -12.67% |
| Mar 31, 2022 | -5.04% |
| Sep 30, 2021 | 16.46% |
| Jun 30, 2021 | -32.55% |
| Mar 31, 2021 | -40.91% |
| Dec 31, 2020 | -28.08% |
| Sep 30, 2020 | -72.97% |